Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Berberine is a compound with glucose-lowering effects in mice and humans. Here, the authors show that in mice berberine has beneficial glycemic effects by promoting insulin secretion, which requires the potassium channel KCNH6 in beta cells, and that berberine can promote insulin secretion in health...
Guardado en:
Autores principales: | Miao-Miao Zhao, Jing Lu, Sen Li, Hao Wang, Xi Cao, Qi Li, Ting-Ting Shi, Kohichi Matsunaga, Chen Chen, Haixia Huang, Testuro Izumi, Jin-Kui Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec84125247fe45d184dfac34b2787232 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interprofessional Continuous Glucose Monitoring for Underserved Adults with Type 2 Diabetes on Insulin or Secretagogues
por: Ife Fasina, et al.
Publicado: (2021) -
Potassium channel-based optogenetic silencing
por: Yinth Andrea Bernal Sierra, et al.
Publicado: (2018) -
A standardised hERG phenotyping pipeline to evaluate KCNH2 genetic variant pathogenicity
por: Barbara Oliveira‐Mendes, et al.
Publicado: (2021) -
Atheroprotective Effects and Molecular Mechanism of Berberine
por: Lu Xing, et al.
Publicado: (2021) -
The expression of ATP-sensitive potassium channels in human umbilical arteries with severe pre-eclampsia
por: Benlan Yin, et al.
Publicado: (2021)